Daniel J. Schneider

4.2k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Daniel J. Schneider is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel J. Schneider has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel J. Schneider's work include Advanced biosensing and bioanalysis techniques (9 papers), Cancer Genomics and Diagnostics (6 papers) and RNA Interference and Gene Delivery (4 papers). Daniel J. Schneider is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), Cancer Genomics and Diagnostics (6 papers) and RNA Interference and Gene Delivery (4 papers). Daniel J. Schneider collaborates with scholars based in United States, Germany and Japan. Daniel J. Schneider's co-authors include Nebojša Janjić, Larry Gold, Michael R. Blackburn, John C. Rohloff, Thale C. Jarvis, Amy D. Gelinas, Urs A. Ochsner, Yang Zhou, Juli Feigon and Zdeněk Hostomský and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Daniel J. Schneider

34 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

2014 370 citations John C. Rohloff, Amy D. Gelinas et al. Molecular Therapy — Nucleic Acids profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Schneider United States	20	1.0k	289	193	192	163	35	1.9k
Ann K. Rosenthal United States	30	508 0.5×	320 1.1×	237 1.2×	118 0.6×	133 0.8×	101	2.9k
Peter Henriksen United Kingdom	20	258 0.2×	236 0.8×	213 1.1×	101 0.5×	113 0.7×	43	1.4k
Atsushi Takahashi Japan	25	891 0.9×	130 0.4×	195 1.0×	193 1.0×	123 0.8×	85	3.0k
Nathan Sandbo United States	24	837 0.8×	543 1.9×	232 1.2×	232 1.2×	139 0.9×	56	2.3k
Anna Myriam Perrone Italy	26	429 0.4×	251 0.9×	346 1.8×	169 0.9×	241 1.5×	165	2.4k
Qi Yang China	23	709 0.7×	270 0.9×	228 1.2×	168 0.9×	114 0.7×	70	1.8k
Valerio Gaetano Vellone Italy	29	443 0.4×	130 0.4×	383 2.0×	51 0.3×	180 1.1×	136	2.2k
Yuping Yuan Australia	26	585 0.6×	390 1.3×	110 0.6×	56 0.3×	110 0.7×	49	2.3k
Guoliang Xu China	17	602 0.6×	184 0.6×	266 1.4×	332 1.7×	116 0.7×	34	1.5k
Kerstin Jurk Germany	27	838 0.8×	522 1.8×	237 1.2×	75 0.4×	199 1.2×	83	3.3k

Countries citing papers authored by Daniel J. Schneider

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Schneider more than expected).

Fields of papers citing papers by Daniel J. Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Schneider. The network helps show where Daniel J. Schneider may publish in the future.

Co-authorship network of co-authors of Daniel J. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Schneider. A scholar is included among the top collaborators of Daniel J. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Schneider. Daniel J. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horgan, Denis, Paul Hofman, Patrizio Giacomini, et al.. (2024). Challenges and barriers for the adoption of personalized medicine in Europe: the case of Oncotype DX Breast Recurrence Score ^® test. Diagnosis. 12(2). 175–181.

Schneider, Daniel J., Clare Paterson, Matthew J. Westacott, et al.. (2024). Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome. Journal of Proteome Research. 23(11). 4771–4788. 9 indexed citations

Gupta, Shashi Kumar, Matthew J. Westacott, Sophie Weiss, et al.. (2023). Plasma proteome of growing tumors. Scientific Reports. 13(1). 12195–12195. 4 indexed citations

Schneider, Daniel J., et al.. (2023). Using Digital Twins to Support Multiple Stages of the Patient Journey. Studies in health technology and informatics. 301. 227–232. 9 indexed citations

Gelinas, Amy D., Tiong Kit Tan, Sai Liu, et al.. (2023). Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents. Molecular Therapy — Nucleic Acids. 31. 370–382. 12 indexed citations

Thiem, Daniel G. E., et al.. (2020). Complications or rather side effects? Quantification of patient satisfaction and complications after orthognathic surgery—a retrospective, cross-sectional long-term analysis. Clinical Oral Investigations. 25(5). 3315–3327. 24 indexed citations

Gawande, Bharat, John C. Rohloff, Jeffrey D. Carter, et al.. (2017). Selection of DNA aptamers with two modified bases. Proceedings of the National Academy of Sciences. 114(11). 2898–2903. 165 indexed citations

Schneider, Daniel J., Peter Riegman, Maureen Cronin, et al.. (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics. 19(3). 160–169. 5 indexed citations

Schneider, Daniel J., Giampaolo Bianchini, Denis Horgan, et al.. (2015). Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care. Public Health Genomics. 18(6). 349–358. 9 indexed citations

10.

Kämmerer, Peer W., Daniel J. Schneider, Eik Schiegnitz, et al.. (2015). Clinical parameter of odontoma with special emphasis on treatment of impacted teeth—a retrospective multicentre study and literature review. Clinical Oral Investigations. 20(7). 1827–1835. 38 indexed citations

11.

Gupta, Shashi Kumar, Masao Hirota, Sheela Waugh, et al.. (2014). Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor. Journal of Biological Chemistry. 289(12). 8706–8719. 125 indexed citations

12.

Rohloff, John C., Amy D. Gelinas, Thale C. Jarvis, et al.. (2014). Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents. Molecular Therapy — Nucleic Acids. 3. e201–e201. 370 indexed citations breakdown →

13.

Wu, Minghua, Daniel J. Schneider, Maureen D. Mayes, et al.. (2012). Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis. Journal of Investigative Dermatology. 132(6). 1605–1614. 74 indexed citations

14.

Mehan, Michael R., Rachel Ostroff, Sheri K. Wilcox, et al.. (2012). Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics, and Therapeutics. Advances in experimental medicine and biology. 735. 283–300. 55 indexed citations

15.

Gupta, Shashi Kumar, Derek Thirstrup, Thale C. Jarvis, et al.. (2011). Rapid Histochemistry Using Slow Off-rate Modified Aptamers With Anionic Competition. Applied immunohistochemistry & molecular morphology. 19(3). 273–278. 41 indexed citations

16.

Pedroza, Mesias, Daniel J. Schneider, Harry Karmouty‐Quintana, et al.. (2011). Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury. PLoS ONE. 6(7). e22667–e22667. 90 indexed citations

17.

Zhou, Yang, Daniel J. Schneider, & Michael R. Blackburn. (2009). Adenosine signaling and the regulation of chronic lung disease. Pharmacology & Therapeutics. 123(1). 105–116. 90 indexed citations

18.

Schneider, Daniel J., et al.. (2009). Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. The FASEB Journal. 24(1). 70–80. 44 indexed citations

19.

Dudek, Arkadiusz Z., Timothy Larson, Michael McCleod, et al.. (2008). Phase 1/2 Dose Escalating Study of Twice-Monthly Pemetrexed and Gemcitabine in Patients with Advanced Cancer and Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(4). 394–399. 16 indexed citations

20.

Schneider, Daniel J., Juli Feigon, Zdeněk Hostomský, & Larry Gold. (1995). High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry. 34(29). 9599–9610. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact